CDK6 and pancreatic adenocarcinoma: For LGG (HR = 1.75, p <.0001) and PAAD (HR = 1.87, p <.001), CDK6 led to a poor prognosis for patients, and the AUC was around 0.7, indicating that it has potential as a biomarker for the clinical prognosis of these tumors.